According to FutureWise analysis the market for Poultry Vaccines in 2023 was US$ 2.04 billion, and is expected to reach US$ 3.68 billion by 2031 at a CAGR of 7.60%.
Vaccines for poultry are widely used to prevent and control contagious poultry diseases. Their use in poultry production is intended to avoid or reduce the emergence of clinical disease at the farm level, thereby increasing production. Vaccines and vaccination programs vary widely depending on several local factors (e.g., type of production, regional disease pattern, costs and potential losses) and are generally managed by the poultry industry. The financial losses caused by the major epidemic diseases of poultry (avian influenza and Newcastle disease) have been enormous in the last decade for both the commercial and public sectors. Vaccination should thus be used in the framework of national or regional poultry disease eradication programs under the official supervision of public veterinary services.
An important part of global agriculture is the poultry industry. Each year, more than 8 billion birds worth more than $20 billion are produced in the US. The majority of the market is made up of broiler chickens. Commercially produced birds are susceptible to a variety of environmental pathogen exposures. As a result, vaccination is a crucial component of flock health management regimens. The current accepted practice in the business is active vaccination utilizing live vaccines. MDV, NDV, IBV, and IBDV are vaccines that are frequently given to hens, whereas NDV and HEV are given to turkeys. Also, being investigated for a commercial application are molecular recombinants, which are vaccines made by putting the genes for immunogenic proteins from infectious organisms into a living viral vector. Adjuvants, notably cytokines, are being used in efforts to increase vaccine efficacy.
Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Poultry-Vaccines-Market/5483
Poultry Vaccines Market Segmentation:
By Product
- Attenuated Live Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- DNA Vaccines
- Recombinant Vaccines
By Disease Type
- Infectious Bronchitis
- Avian Influenza
- Marek’s Disease
- Newcastle Disease
- Salmonella
By Application
- Breeder
- Broiler
- Layer
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Poultry Vaccines Market:
- Merck & Co. Inc.
- Zoetis
- Boehringer Ingelheim International GmbH
- Ceva
- Hester Biosciences Limited
- Anicon GmbH
- Ringpu Biology
- Elanco
- Phibro Animal Health Corporation
- Indovax
- Harbin Veterinary Research Institute
Ask For Discount: https://www.futurewiseresearch.com/contact.aspx?rpt=5483%20&type=discount
**Objectives of this Study: **
- To provide a comprehensive analysis of the Poultry Vaccines Market By Product, By Disease Type, By Application and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
FutureWise Research
Contact Person: Vinay Thaploo.
Email: sales@futurewiseresearch.com
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com
